Suppr超能文献

直接测量分娩入院时严重产妇发病率事件与无并发症分娩的成本。

Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries.

机构信息

Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of Utah Health, Salt Lake City, Utah.

Division of Maternal-Fetal Medicine, Women and Newborns Clinical Program, Intermountain Healthcare, Salt Lake City, Utah.

出版信息

Am J Perinatol. 2022 Apr;39(6):567-576. doi: 10.1055/s-0041-1740237. Epub 2021 Dec 2.

Abstract

OBJECTIVE

To estimate the actual excess costs of care for delivery admissions complicated by severe maternal morbidity (SMM) compared with uncomplicated deliveries.

STUDY DESIGN

This is a retrospective cohort study of all deliveries between October 2015 and September 2018 at a single tertiary academic center. Pregnant individuals ≥ 20 weeks' gestation who delivered during a hospital admission (i.e., a "delivery admission") were included. The primary exposure was SMM, as defined by Centers for Disease Control and Prevention (CDC) criteria, CDC criteria excluding blood transfusion, or by validated hospital-defined criteria (intensive care unit admission or ≥ 4 units of blood products). Potential SMM events identified via administrative and blood bank data were reviewed to confirm SMM events had occurred. Primary outcome was total actual costs of delivery admission derived from time-based accounting and acquisition costs in the institutional Value Driven Outcomes database. Cost of delivery admissions with SMM events was compared with the cost of uncomplicated delivery using adjusted generalized linear models, with separate models for each of the SMM definitions. Relative cost differences are reported due to data restrictions.

RESULTS

Of 12,367 eligible individuals, 12,361 had complete cost data. Two hundred and eighty individuals (2.3%) had confirmed SMM events meeting CDC criteria. CDC criteria excluding transfusion alone occurred in 1.0% ( = 121) and hospital-defined SMM in 0.6% ( = 76). In adjusted models, SMM events by CDC criteria were associated with a relative cost increase of 2.45 times (95% confidence interval [CI]: 2.29-2.61) the cost of an uncomplicated delivery. SMM by CDC criteria excluding transfusion alone was associated with a relative increase of 3.26 (95% CI: 2.95-3.60) and hospital-defined SMM with a 4.19-fold (95% CI: 3.64-4.83) increase. Each additional CDC subcategory of SMM diagnoses conferred a relative cost increase of 1.60 (95% CI: 1.43-1.79).

CONCLUSION

SMM is associated with between 2.5- and 4-fold higher cost than uncomplicated deliveries.

KEY POINTS

· Severe maternal morbidity as defined by CDC criteria confers a 2.5-fold increase in delivery hospitalization costs.. · Intensive care unit admission or ≥ 4 units of blood products confer a fourfold increase in cost.. · Costs of maternal morbidity may motivate SMM review..

摘要

目的

估计与无并发症分娩相比,严重产妇发病率(SMM)导致的分娩入院的实际额外护理成本。

研究设计

这是一项对 2015 年 10 月至 2018 年 9 月在一家三级学术中心进行的所有分娩的回顾性队列研究。纳入妊娠 20 周以上并在住院期间分娩的个体(即“分娩入院”)。主要暴露因素是 SMM,由疾病预防控制中心(CDC)标准定义,不包括输血的 CDC 标准,或由经过验证的医院定义的标准(重症监护病房入院或≥4 单位的血液制品)。通过行政和血库数据识别的潜在 SMM 事件经过审查以确认 SMM 事件已发生。主要结局是从机构价值驱动结果数据库中的基于时间的核算和获取成本中得出的分娩入院的实际总成本。使用调整后的广义线性模型比较有 SMM 事件的分娩入院成本与无并发症分娩成本,每个 SMM 定义都有一个单独的模型。由于数据限制,报告了相对成本差异。

结果

在 12367 名符合条件的个体中,有 12361 名个体具有完整的成本数据。280 名个体(2.3%)有经确认的符合 CDC 标准的 SMM 事件。单独使用输血的 CDC 标准占 1.0%( = 121),医院定义的 SMM 占 0.6%( = 76)。在调整后的模型中,符合 CDC 标准的 SMM 事件与无并发症分娩成本的相对增加 2.45 倍(95%置信区间[CI]:2.29-2.61)。仅排除输血的单独使用的 CDC 标准相关 SMM 与相对增加 3.26(95% CI:2.95-3.60)相关,而医院定义的 SMM 与增加 4.19 倍(95% CI:3.64-4.83)相关。每个额外的 CDC SMM 诊断亚类与相对成本增加 1.60(95% CI:1.43-1.79)相关。

结论

SMM 与无并发症分娩相比,成本增加 2.5-4 倍。

关键点

·CDC 标准定义的严重产妇发病率导致分娩住院费用增加 2.5 倍。·重症监护病房入院或≥4 单位血液制品的费用增加 4 倍。·产妇发病率的成本可能会促使对 SMM 进行审查。

相似文献

1
Directly Measured Costs of Severe Maternal Morbidity Events during Delivery Admission Compared with Uncomplicated Deliveries.
Am J Perinatol. 2022 Apr;39(6):567-576. doi: 10.1055/s-0041-1740237. Epub 2021 Dec 2.
3
Severe Maternal Morbidity Associated with Hospital NICU Level in Washington State.
Am J Perinatol. 2021 Nov;38(13):1335-1340. doi: 10.1055/s-0041-1732452. Epub 2021 Jul 16.
4
The Positive Predictive Value of Hospital Discharge Data for Identifying Severe Maternal Morbidity With and Without Blood Transfusion.
Jt Comm J Qual Patient Saf. 2023 Sep;49(9):467-473. doi: 10.1016/j.jcjq.2023.05.004. Epub 2023 May 26.
5
Confirmed severe maternal morbidity is associated with high rate of preterm delivery.
Am J Obstet Gynecol. 2016 Aug;215(2):233.e1-7. doi: 10.1016/j.ajog.2016.02.026. Epub 2016 Feb 17.
7
Using Potentially Preventable Severe Maternal Morbidity to Monitor Hospital Performance.
Jt Comm J Qual Patient Saf. 2023 Mar;49(3):129-137. doi: 10.1016/j.jcjq.2022.11.007. Epub 2022 Nov 19.
8
The Association between Sickle Cell Disease and Postpartum Severe Maternal Morbidity.
Am J Perinatol. 2024 Nov;41(15):2144-2151. doi: 10.1055/s-0044-1786174. Epub 2024 Apr 23.
10
Adverse Delivery and Neonatal Outcomes Among Women with Severe Maternal Morbidity in Illinois, 2018-2019.
J Womens Health (Larchmt). 2024 Feb;33(2):163-170. doi: 10.1089/jwh.2023.0248. Epub 2023 Nov 16.

引用本文的文献

1
Unpacking childbirth expenditures: what are the factors driving extreme costs in Serbia?
BMC Pregnancy Childbirth. 2025 Jul 21;25(1):780. doi: 10.1186/s12884-025-07889-2.
2
Care of pregnant women with pre-existing medical conditions in German perinatal centers.
Arch Gynecol Obstet. 2025 Apr 7. doi: 10.1007/s00404-025-08016-4.
3
Maternal Morbidity and Medically Assisted Reproduction Treatment Types.
Obstet Gynecol. 2025 Feb 1;145(2):220-230. doi: 10.1097/AOG.0000000000005808. Epub 2024 Dec 19.
4
Burden of Medical Costs Associated with Severe Maternal Morbidity in South Korea.
Healthcare (Basel). 2024 Dec 2;12(23):2414. doi: 10.3390/healthcare12232414.
5
Cardiovascular Disease in Pregnancy: Clinical Outcomes and Cost-Associated Burdens From a National Cohort at Delivery.
JACC Adv. 2024 Jul 2;3(8):101071. doi: 10.1016/j.jacadv.2024.101071. eCollection 2024 Aug.
6
Ranked severe maternal morbidity index for population-level surveillance at delivery hospitalization based on hospital discharge data.
PLoS One. 2023 Nov 9;18(11):e0294140. doi: 10.1371/journal.pone.0294140. eCollection 2023.
7
Rural-Urban Disparities in Adverse Maternal Outcomes in the United States, 2016-2019.
Am J Public Health. 2023 Feb;113(2):224-227. doi: 10.2105/AJPH.2022.307134.

本文引用的文献

1
Cost of Elective Labor Induction Compared With Expectant Management in Nulliparous Women.
Obstet Gynecol. 2020 Jul;136(1):19-25. doi: 10.1097/AOG.0000000000003930.
3
The REDCap consortium: Building an international community of software platform partners.
J Biomed Inform. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208. Epub 2019 May 9.
4
Evaluation of cost and survival in intracranial gliomas using the Value Driven Outcomes database: a retrospective cohort analysis.
J Neurosurg. 2019 Mar 29;132(4):1006-1016. doi: 10.3171/2018.12.JNS183109. Print 2020 Apr 1.
5
Maternal obesity and severe maternal morbidity-It is time to ask new research questions.
Paediatr Perinat Epidemiol. 2019 Jan;33(1):17-18. doi: 10.1111/ppe.12533. Epub 2019 Jan 11.
6
Preventability review of severe maternal morbidity.
Acta Obstet Gynecol Scand. 2019 Apr;98(4):515-522. doi: 10.1111/aogs.13526. Epub 2019 Jan 28.
7
Severe Maternal Morbidity and Hospital Cost among Hospitalized Deliveries in the United States.
Am J Perinatol. 2018 Nov;35(13):1287-1296. doi: 10.1055/s-0038-1649481. Epub 2018 May 3.
8
Maternal Mortality in the United States: A Review of Contemporary Data and Their Limitations.
Clin Obstet Gynecol. 2018 Jun;61(2):296-306. doi: 10.1097/GRF.0000000000000362.
9
Understanding Severe Maternal Morbidity: Hospital-based Review.
Clin Obstet Gynecol. 2018 Jun;61(2):340-346. doi: 10.1097/GRF.0000000000000351.
10
Estimating the Hospital Delivery Costs Associated With Severe Maternal Morbidity in New York City, 2008-2012.
Obstet Gynecol. 2018 Feb;131(2):242-252. doi: 10.1097/AOG.0000000000002432.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验